Jbe, whether it's Lot 1 or Lot 6 doesn't guarantee sales and thus revenue for Nuheara. If audiologist are involved then the majority will push to sell higher value items (hearing aids) for a higher commission.
The OTC deregulation in the US will be the game changer and overtime the rest of the world will follow this trend.
Nuheara currently meet all 3 requirements for Boost and soon Max for OTC when it is passed in 2020.
I'm curious why you didn't post the attached annex as part of the response? I would love to see it.
Cheers.
acca
Jbe, whether it's Lot 1 or Lot 6 doesn't guarantee...
-
- There are more pages in this discussion • 177 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NUH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.75M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| NUH (ASX) Chart |
Day chart unavailable